Pancreatic Cancer Research

ResearcherTechnion – Israel Institute of TechnologyNo recent work listed

Yuval Shaked

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9037-3895; OpenAlex author ID A5068166516. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
3
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper

Papers 3

  1. Elucidating the roles of ASPM isoforms reveals a novel prognostic marker for pancreatic cancer. First author DOI 10.1002/path.5355↗
  2. Next Viable Routes to Targeting Pancreatic Cancer Stemness: Learning from Clinical Setbacks. Last author DOI 10.3390/jcm8050702↗
  3. Anti-Bv8 antibody and metronomic gemcitabine improve pancreatic adenocarcinoma treatment outcome following weekly gemcitabine therapy. Last author DOI 10.1016/j.neo.2014.05.011↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael Timaner · 1 shared paper, 2020 · strength 0.24
  2. Kelvin K. Tsai · 1 shared paper, 2019 · strength 0.16
  3. Erez Hasnis · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.